Created in 2007 (United States), CARDIOGENESIS own 14 sister brands and 2279 competing brands. CARDIOGENESIS is a brand of Cryolife, listed on the stock exchange of New York. CARDIOGENESIS belongs to the Medical Devices & Instruments business sector.

CARDIOGENESIS is a brand of Cryolife (AORT) Share price

Share price and profitability of the share Cryolife (CARDIOGENESIS)

Buy Cryolife share with

(0% commission and fractional shares)

Your capital is subject to risk. Other fees apply. For more information, visit etoro.com/trading/fees.

Investment simulator :

Amount invested USD 20.47

Portfolio valuation
Cryolife (CARDIOGENESIS) over 5 years* USD 13.60

Stock market history Cryolife (CARDIOGENESIS)

Market prices -> Notoriety

*non inclusive of dividends, non inclusive of market orders
past performances do not prejudice future performances

Other brands
Cryolife

See more brands of Cryolife

Rival brands
CARDIOGENESIS

Technology Assessment and Transfer

Sintx Technologies

OTHER RIVAL BRANDS

Top Popularity Web

See the full ranking